GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 09, 2026, titled "Press Release".
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals Limited has submitted a notification to the stock exchanges regarding a press release dated February 09, 2026 titled 'Press Release'. The actual contents of the press release have not been shared in this filing notice. No specific financial figures, business updates, or strategic announcements are visible in the intimation itself. Retail investors would need to access the actual press release document to understand the substance of the communication.
Without the actual press release content, it is not possible to assess the impact on the stock price or shareholders. Investors should look for the attached press release for details on the subject matter.